SCHEMBL4768768

SCHEMBL4768768

CS(=O)(=O)c1ccc(CCNc2cc(-c3cccnc3)nc(-c3ccccn3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 5/20 0.53
GPR39 O43194 1/20 0.51
ADORA2A P29274 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
PTGS2 P35354 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PPP1CA P62136 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPK14 Q16539 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
JAK2 O60674 1/20 0.42
PTK2 Q05397 1/20 0.42
HIF1A Q16665 1/20 0.41
CYP2A6 P11509 1/20 0.41
METAP2 P50579 2/20 0.41
METAP1 P53582 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771978 0.90 PTGDR (0.51) PTGDRCYP3A4CYP2C9PTGS2SMN1; SMN2
SCHEMBL2242475 0.86 PTGDR (0.54) PTGDRCYP3A4CYP2C9SMN1; SMN2PPP1CA
SCHEMBL2238098 0.86 PTGDR (0.53) PTGDRCYP3A4CYP2C9SMN1; SMN2PPP1CA
SCHEMBL2237693 0.85 PTGDR (0.73) PTGDRADORA2A
SCHEMBL2240945 0.81 GBA1 (0.54) PTGDRCYP3A4CYP2C9SMN1; SMN2PPP1CA
SCHEMBL2239971 0.81 SMN1; SMN2 (0.53) PTGDRCYP3A4CYP2C9SMN1; SMN2PPP1CA
SCHEMBL2237320 0.80 HIF1A (0.47) PTGDRCYP3A4CYP2C9SMN1; SMN2PPP1CA
SCHEMBL2238820 0.80 PTGDR (0.48) PTGDRCYP3A4CYP2C9SMN1; SMN2L3MBTL1
SCHEMBL2241291 0.80 KMT2A (0.46) PTGDRGPR39CYP3A4CYP2C9PTGS2
SCHEMBL2238638 0.79 PTGDR (0.47) PTGDRCYP3A4CYP2C9SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed